Smyth2
Bluelighter
- Joined
- Jul 26, 2011
- Messages
- 725
3-(1H-indol-3-yl)-N,N-dimethylcyclobutan-1-amine
3-(1H-indol-3-yl)-N,N-dimethylcyclobutan-1-amine | C14H18N2 | CID 140974575 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.
Leads to this triptan:
4991W93
(4S)-4-[[3-[3-(Dimethylamino)cyclobutyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one
[171549-56-7]
Jandu KS, Barrett V, Brockwell M, Cambridge D, Farrant DR, Foster C, Giles H, Glen RC, Hill AP, Hobbs H, Honey A, Martin GR, Salmon J, Smith D, Woollard P, Selwood DL. Discovery of 4-[3-(trans-3-dimethylaminocyclobutyl)-1H-indol-5-ylmethyl]-(4S)-oxazolidin-2-one (4991W93), a 5HT(1B/1D) receptor partial agonist and a potent inhibitor of electrically induced plasma extravasation. J Med Chem. 2001 Mar 1;44(5):681-93. doi: 10.1021/jm000956k. PMID: 11262079.
Robert Charles Glen, et al. WO1995020588 (to Wellcome Foundation Ltd, SmithKline Beecham Corp).
